What customer reviews of Wegovy tell you — and what the clinical evidence adds

What the published evidence says people actually experience on Wegovy

The STEP 1 trial randomised 1,961 adults with obesity or overweight plus a weight-related condition and followed them for 68 weeks. Participants taking semaglutide 2.4mg lost an average of around 15% body weight compared with around 2.4% on placebo. Around one in three reached at least 20% weight loss. Those are averages across a large group, the spread around them is wide, which is exactly why individual accounts vary so much.

What the trial also captured was the side-effect picture. Gastrointestinal symptoms (nausea most often, followed by diarrhoea, vomiting and constipation) were reported by the majority of participants at some point, particularly in the early weeks of treatment and after each dose increase. Most described them as mild to moderate and temporary. A smaller proportion found them persistent enough to reduce their dose or stop. That matches the pattern seen in real-world reviews: people who titrated slowly and adjusted eating habits generally report a smoother ride than those who pushed through difficult symptoms without support.

The NHS semaglutide medicines page covers the recognised side-effect profile clearly, including which symptoms warrant prompt medical attention. It's worth a read before starting, not only once something feels wrong.

Why reviews at different dose stages can look like they're describing different medicines

Wegovy is titrated over several months. The starting dose of 0.25mg is not where the weight-loss effect sits, it exists to let your system adjust. Most people reach the 2.4mg maintenance dose after around five months of stepping up through 0.5mg, 1.0mg and 1.7mg. Reviews written at week four are almost always describing an early, low-dose experience; reviews written at month nine are describing something quite different.

That's partly why accounts differ so sharply online. Someone who stopped at 1.0mg because of nausea and someone who reached 2.4mg and stayed there for a year are both writing genuine reviews, they just didn't have the same treatment. If you're comparing accounts focused on Wegovy side effects with those focused on results, that dose-stage gap explains a lot of the contradiction. For a closer look at how people describe the experience of the 0.5mg titration step specifically, our collection of Wegovy 0.5mg reviews reflects what that early stage tends to feel like in practice.

A prescriber can help frame what to expect at each stage and whether your own trajectory looks typical. That conversation matters more than any single five-star or one-star account.

The gap between what reviews capture and what they miss

Online reviews, even genuine ones, tend to skew toward strong experiences. People who lost significant weight and people who had a difficult time both have reason to write; those with an ordinary, steady experience often don't. That selection effect means the average review pool overrepresents the extremes relative to the clinical trial population.

Reviews also rarely mention what else was happening: whether the person was working with a dietitian, how consistently they attended follow-up reviews, whether they had a dose reduction, or whether they were also managing a condition that affects weight. The STEP 1 trial included structured lifestyle support alongside semaglutide, a detail that matters when reading accounts where lifestyle context is absent.

For a more granular look at how results play out across the treatment period, the Wegovy weight-loss reviews page breaks down what different stages of treatment typically look like. And for context on what the treatment costs privately, our Wegovy pricing page covers what an all-inclusive private prescription involves.

What legitimacy checks reviews can't do for you

One thing no review (however detailed) can tell you is whether the medicine being described was genuine. The MHRA has warned repeatedly about counterfeit weight-loss pens circulating through online sellers and social media. Fake pens have been found to contain the wrong substance entirely. Reviews of those products would obviously look very different from reviews of licensed Wegovy, and there's no way to know from the text alone.

The one-minute check worth doing: any pharmacy supplying Wegovy in the UK must be registered with the GPhC. You can search by name or registration number at the GPhC pharmacy register. If a seller isn't listed, stop there. At nume, our GPhC registration is 9012878, verifiable on that register directly. Every prescription is reviewed personally by a GPhC-registered Independent Prescriber, not automated software, before any medicine is dispensed.

If you've read enough and want to understand whether Wegovy is clinically suitable for you, you can find out what the process involves as a new Wegovy customer, read what verified patients say about their experience with Wegovy, or start a free consultation and have your answers reviewed by a prescriber the same day.